Show simple item record

dc.contributor.authorDijksterhuis, WPM
dc.contributor.authorStroes, CI
dc.contributor.authorTan, W-L
dc.contributor.authorIthimakin, S
dc.contributor.authorCalles, A
dc.contributor.authorvan Oijen, MGH
dc.contributor.authorVerhoeven, RHA
dc.contributor.authorBarriuso, J
dc.contributor.authorOosting, SF
dc.contributor.authorIvankovic, DK
dc.contributor.authorFurness, AJS
dc.contributor.authorBozovic-Spasojevic, I
dc.contributor.authorGomez-Roca, C
dc.contributor.authorvan Laarhoven, HWM
dc.date.accessioned2020-08-25T15:41:24Z
dc.date.issued2020-06
dc.identifier.citationInternational journal of cancer, 2020, 146 (11), pp. 3011 - 3021
dc.identifier.issn0020-7136
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4003
dc.identifier.eissn1097-0215
dc.identifier.doi10.1002/ijc.32660
dc.description.abstractGender disparities in scientific publications have been identified in oncological research. Oral research presentations at major conferences enhance visibility of presenters. The share of women presenting at such podia is unknown. We aim to identify gender-based differences in contributions to presentations at two major oncological conferences. Abstracts presented at plenary sessions of the American Society of Clinical Oncology (ASCO) Annual Meetings and European Society for Medical Oncology (ESMO) Congresses were collected. Trend analyses were used to analyze female contribution over time. The association between presenter's sex, study outcome (positive/negative) and journals' impact factors (IFs) of subsequently published papers was assessed using Chi-square and Mann-Whitney U tests. Of 166 consecutive abstracts presented at ASCO in 2011-2018 (n = 34) and ESMO in 2008-2018 (n = 132), 21% had female presenters, all originating from Northern America (n = 17) or Europe (n = 18). The distribution of presenter's sex was similar over time (p = 0.70). Of 2,425 contributing authors to these presented abstracts, 28% were women. The proportion of female abstract authors increased over time (p < 0.05) and was higher in abstracts with female (34%) compared to male presenters (26%; p < 0.01). Presenter's sex was not associated with study outcome (p = 0.82). Median journals' IFs were lower in papers with a female first author (p < 0.05). In conclusion, there is a clear gender disparity in research presentations at two major oncological conferences, with 28% of authors and 21% of presenters of these studies being female. Lack of visibility of female presenters could impair acknowledgement for their research, opportunities in their academic career and even hamper heterogeneity in research.
dc.formatPrint-Electronic
dc.format.extent3011 - 3021
dc.languageeng
dc.language.isoeng
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectHumans
dc.subjectMedical Oncology
dc.subjectSocieties, Medical
dc.subjectFemale
dc.subjectMale
dc.subjectSexism
dc.subjectScholarly Communication
dc.subjectGender Equity
dc.titleFrom presentation to paper: Gender disparities in oncological research.
dc.typeJournal Article
dcterms.dateAccepted2019-08-07
rioxxterms.versionofrecord10.1002/ijc.32660
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2020-06
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfInternational journal of cancer
pubs.issue11
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.publication-statusPublished
pubs.volume146
pubs.embargo.termsNot known
dc.contributor.icrauthorFurness, Andrewen


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0